Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
Zacks.com on MSN23h
Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key Metrics
Analysts on Wall Street project that Moderna (MRNA) will announce quarterly loss of $2.65 per share in its forthcoming report, representing a decline of 581.8% year over year. Revenues are projected ...
5 Struggling Stocks That Might Be Buys
To that end, co-founder Bespoke Investment Group Justin Walters compiled a list of S&P 500 stocks that have tumbled more ...
Bird flu latest updates: Hundreds of eggs stolen from Seattle cafe in 2nd egg heist as prices have soared
Yahoo News provides the latest updates on the spread of bird flu in the U.S., and its effect on rising egg prices and ...